个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Chen, Chun-yan[1,2,3,4,5,6,7,8,9,10] ; Zhao, Chong[1,2,3,4,5,6,7,8,9,10] ; Gao, Li[1,2,3,4,5,6,7,8,9,10] ; Lang, Jin-yi[1,2,3,4,5,6,7,8,9,10] ; Pan, Jian-ji[1,2,3,4,5,6,7,8,9,10] ; Hu, Chao-su[1,2,3,4,5,6,7,8,9,10] ; Jin, Feng[1,2,3,4,5,6,7,8,9,10] ; Wang, Ren-sheng[1,2,3,4,5,6,7,8,9,10] ; Xie, Conghua[1,2,3,4,5,6,7,8,9,10] ; Lin, Tongyu[1,2,3,4,5,6,7,8,9,10] ; Lu, Tai-xiang[1,2,3,4,5,6,7,8,9,10] ;
机构： [1]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China [2]Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China [3]Sichuan Canc Hosp, Chengdu, Peoples R China [4]Fujian Canc Hosp, Fuzhou, Peoples R China [5]Fudan Univ, Ctr Canc, Shanghai 200433, Peoples R China [6]Guizhou Canc Hosp, Guiyang, Peoples R China [7]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [8]Wuhan Univ, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China [9]Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Peoples R China [10]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2012]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2012]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者：
推荐引用方式(GB/T 7714)：
Chen Chun-yan,Zhao Chong,Gao Li,et al.An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report[J].JOURNAL OF CLINICAL ONCOLOGY.2012,30(15):
APA：
Chen, Chun-yan,Zhao, Chong,Gao, Li,Lang, Jin-yi,Pan, Jian-ji...&Lu, Tai-xiang.(2012).An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report.JOURNAL OF CLINICAL ONCOLOGY,30,(15)
MLA：
Chen, Chun-yan,et al."An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report".JOURNAL OF CLINICAL ONCOLOGY 30..15(2012)

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号